Literature DB >> 32978606

When de novo-designed protein logics meet CAR-T therapies.

Mingqi Xie1,2,3,4, Peilong Lu5,6,7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32978606      PMCID： PMC7784840          DOI： 10.1038/s41422-020-00419-z

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  10 in total

1.  Programmable design of orthogonal protein heterodimers.

Authors:  Zibo Chen; Scott E Boyken; Mengxuan Jia; Florian Busch; David Flores-Solis; Matthew J Bick; Peilong Lu; Zachary L VanAernum; Aniruddha Sahasrabuddhe; Robert A Langan; Sherry Bermeo; T J Brunette; Vikram Khipple Mulligan; Lauren P Carter; Frank DiMaio; Nikolaos G Sgourakis; Vicki H Wysocki; David Baker
Journal:  Nature       Date:  2018-12-19       Impact factor: 49.962

Review 2.  The coming of age of de novo protein design.

Authors:  Po-Ssu Huang; Scott E Boyken; David Baker
Journal:  Nature       Date:  2016-09-15       Impact factor: 49.962

3.  BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells.

Authors:  Kyle K Payne; Jessica A Mine; Subir Biswas; Ricardo A Chaurio; Alfredo Perales-Puchalt; Carmen M Anadon; Tara Lee Costich; Carly M Harro; Jennifer Walrath; Qianqian Ming; Evgenii Tcyganov; Andrea L Buras; Kristen E Rigolizzo; Gunjan Mandal; Jason Lajoie; Michael Ophir; Julia Tchou; Douglas Marchion; Vincent C Luca; Piotr Bobrowicz; Brooke McLaughlin; Ugur Eskiocak; Michael Schmidt; Juan R Cubillos-Ruiz; Paulo C Rodriguez; Dmitry I Gabrilovich; Jose R Conejo-Garcia
Journal:  Science       Date:  2020-08-21       Impact factor: 47.728

Review 4.  The approved gene therapy drugs worldwide: from 1998 to 2019.

Authors:  Cui-Cui Ma; Zhen-Ling Wang; Ting Xu; Zhi-Yao He; Yu-Quan Wei
Journal:  Biotechnol Adv       Date:  2019-12-27       Impact factor: 14.227

5.  De novo design of protein logic gates.

Authors:  Zibo Chen; Ryan D Kibler; Andrew Hunt; Florian Busch; Jocelynn Pearl; Mengxuan Jia; Zachary L VanAernum; Basile I M Wicky; Galen Dods; Hanna Liao; Matthew S Wilken; Christie Ciarlo; Shon Green; Hana El-Samad; John Stamatoyannopoulos; Vicki H Wysocki; Michael C Jewett; Scott E Boyken; David Baker
Journal:  Science       Date:  2020-04-03       Impact factor: 47.728

6.  T lymphocytes expressing a CD16 signaling receptor exert antibody-dependent cancer cell killing.

Authors:  Ko Kudo; Chihaya Imai; Paolo Lorenzini; Takahiro Kamiya; Koji Kono; Andrew M Davidoff; Wee Joo Chng; Dario Campana
Journal:  Cancer Res       Date:  2013-11-06       Impact factor: 12.701

7.  Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses.

Authors:  Jang Hwan Cho; James J Collins; Wilson W Wong
Journal:  Cell       Date:  2018-04-26       Impact factor: 41.582

8.  Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits.

Authors:  Kole T Roybal; Levi J Rupp; Leonardo Morsut; Whitney J Walker; Krista A McNally; Jason S Park; Wendell A Lim
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

9.  SYNZIP protein interaction toolbox: in vitro and in vivo specifications of heterospecific coiled-coil interaction domains.

Authors:  Kenneth Evan Thompson; Caleb J Bashor; Wendell A Lim; Amy E Keating
Journal:  ACS Synth Biol       Date:  2012-04-20       Impact factor: 5.110

10.  De novo design of bioactive protein switches.

Authors:  Robert A Langan; Scott E Boyken; Andrew H Ng; Jennifer A Samson; Galen Dods; Alexandra M Westbrook; Taylor H Nguyen; Marc J Lajoie; Zibo Chen; Stephanie Berger; Vikram Khipple Mulligan; John E Dueber; Walter R P Novak; Hana El-Samad; David Baker
Journal:  Nature       Date:  2019-07-24       Impact factor: 49.962
  10 in total
  1 in total

Review 1.  Recent Progress Using De Novo Design to Study Protein Structure, Design and Binding Interactions.

Authors:  Juan Ferrando; Lee A Solomon
Journal:  Life (Basel)       Date:  2021-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.